From: Recent advances in exosome-mediated nucleic acid delivery for cancer therapy
Types | Sources | Advantages | Disadvantages | References |
---|---|---|---|---|
Cell-secreted exosomes | Human embryonic kidney cells | Ease of growth; non-demanding maintenance conditions; high transfection efficiency; ideal host cells for membrane modification through gene manipulation | Immune inert | [23] |
Cancer cells | Large secretion; targeting homotypic tumor | Have a less ideal pharmacokinetic profile; be involved in tumour development and metastasis; having potential safety issues | [30] | |
Immune cells (e. g. macrophage cells, dendritic cells, natural killer cells) | Reduced immunogenicity; inducing potent cellular immune responses; containing killer proteins and cytotoxic molecules to inhibit tumour growth; penetrating the blood–brain barrier | Lack of understanding of mechanisms regarding how exosomal components interact with acceptor cells | [10] | |
Stem cells (e. g. mesenchymal stem cells) | Immune regulation characteristics; low production cost; good homing and penetrating ability | The unclear cargo composition of exosomes and biological behavior mechanism | ||
Blood-derived exosomes | Blood | Wide source and easy access; reduced unexpected mutations in cell culture; no occurring horizontal gene transfer; high transfection efficiency; natural brain targeting ability | Not determined | [33] |
Food-derived exosomes | Milk-derived exosomes | Rich sources; crossing through the gastrointestinal tract via the neonatal Fc receptor; improving the oral bioavailability of drugs; improving the effectiveness and stability of drugs; improving human and mouse intestinal cells | Variation in shape, size, and cargo contents of exosomes; the unclear mechanism of the absorption, movement, and action | |
Plants-derived exosomes (e. g. grape, strawberry, lemon) | Rich sources; have the stability in the digestive environment | Less understanding of the ability in the process; the unclear mechanism of the absorption, movement, and action |